← Evidence map

ArticleFrontiers in pharmacology2023

Efficacy and safety evaluation of Azvudine in the prospective treatment of COVID-19 based on four phase III clinical trials.

Ke-Wei ZhuPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

16 papers cite it

2023
2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 37693894